rs2073658
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_007122.5(USF1):c.561-100G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 1,466,922 control chromosomes in the GnomAD database, including 50,584 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.22 ( 4290 hom., cov: 31)
Exomes 𝑓: 0.26 ( 46294 hom. )
Consequence
USF1
NM_007122.5 intron
NM_007122.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
USF1 (HGNC:12593): (upstream transcription factor 1) This gene encodes a member of the basic helix-loop-helix leucine zipper family, and can function as a cellular transcription factor. The encoded protein can activate transcription through pyrimidine-rich initiator (Inr) elements and E-box motifs. This gene has been linked to familial combined hyperlipidemia (FCHL). Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been defined on chromosome 21. [provided by RefSeq, Feb 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.275 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USF1 | NM_007122.5 | c.561-100G>A | intron_variant | ENST00000368021.7 | NP_009053.1 | |||
USF1 | NM_001276373.2 | c.561-100G>A | intron_variant | NP_001263302.1 | ||||
USF1 | NM_207005.3 | c.384-100G>A | intron_variant | NP_996888.1 | ||||
USF1 | XM_047429959.1 | c.384-100G>A | intron_variant | XP_047285915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USF1 | ENST00000368021.7 | c.561-100G>A | intron_variant | 1 | NM_007122.5 | ENSP00000357000 | P1 |
Frequencies
GnomAD3 genomes AF: 0.216 AC: 32772AN: 151874Hom.: 4287 Cov.: 31
GnomAD3 genomes
AF:
AC:
32772
AN:
151874
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.259 AC: 341020AN: 1314930Hom.: 46294 AF XY: 0.257 AC XY: 168312AN XY: 654562
GnomAD4 exome
AF:
AC:
341020
AN:
1314930
Hom.:
AF XY:
AC XY:
168312
AN XY:
654562
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.216 AC: 32772AN: 151992Hom.: 4290 Cov.: 31 AF XY: 0.216 AC XY: 16033AN XY: 74278
GnomAD4 genome
AF:
AC:
32772
AN:
151992
Hom.:
Cov.:
31
AF XY:
AC XY:
16033
AN XY:
74278
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
469
AN:
3478
ClinVar
Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Hyperlipidemia, familial combined, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Sep 01, 2005 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at